Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE ®) to current standard-of-care ...
Pfizer Inc. and Alliance Foundation Trials, LLC (AFT) announced results from the phase 3 PATINA trial demonstrating that the addition of Ibrance (palbociclib) to current standard-of-care first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback